Abstract
Apoptosis seems to be the predominant type of active cell death in the liver (type I), while in other tissues cells may die via biochemically and morphologically different pathways (type II, type III). Active cell death is under the control of growth factors and death signals. In the liver, endogenous factors, such as transforming growth factor β1 (TGF-β1), activin A, CD95 ligand, and tumor necrosis factor (TNF) may be involved in induction of apoptosis. Release and action of these death factors seems to be triggered by exogenous signals such as withdrawal of hepato-mitogens, food restriction, etc.
During stages of hepatocarcinogenesis, not only DNA synthesis but also apoptosis gradually increase from normal to preneoplastic to adenoma and carcinoma tissue. Also, in human carcinomas, birth and death rates of cells are several times higher than in surrounding liver. (Pre)neoplastic liver cells are more susceptible than normal hepatocytes to stimulation of cell replication and of cell death. Consequently, tumor promoters may act as survival factors, i.e., inhibit apoptosis preferentially in preneoplastic and even in malignant liver cells, thereby stimulating selective growth of (pre)neoplastic lesions. On the other hand, regimens favoring apoptosis and lowering cell replication may result in selective elimination of (pre)neoplastic cell clones from the liver. Finally, we have studied the first stage of carcinogenesis, namely the appearance of putatively initiated cells after a single dose of the genotoxic carcinogen N-nitrosomorpholine (NNM). Most of these cells were found to be eliminated by apoptosis, suggesting that initiation, at the organ level, can be reversed at least partially by preferential elimination of initiated cells. These events may be regulated by autocrine or paracrine actions of survival factors.
Similar content being viewed by others
References
Beaulaton J, Lockshin RA. Ultrastructural study of the normal degeneration of the intersegmental muscles of Anthereae polyphemus and Manduca sexta (Insecta, Lepidoptera) with particular reference of cellular autophagy). J Morphol. 1977;154:39–57.
Bursch W, Lauer B, Timmermann-Trosiener T, Barthel G, Schuppler J, Schulte-Hermann R. Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcino-genesis. 1984;5:53–8.
Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis. 1990;11:847–53.
Bursch W, Oberhammer F, Jirtle RL et al. Transforming growth factor-b1 as a signal for induction of cell death by apoptosis. Br J Cancer. 1993;67:531–6.
Bursch W, Ellinger A, Kienzl H et al. Active cell death induced by the antiestrogen tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis. 1996;17:1595–607.
Clarke PGH. Developmental cell death: morphological diver-sity and multiple mechanisms. Anat Embryol. 1990;181: 195–213.
Collins RJ, Harmon BK, Gobe GC, Kerr JFR. Internucleoso-mal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol. 1992;61:451–3.
Farber E, Verbin RS, Lieberman M. Cell suicide and cell death. In: Aldridge N, ed. A symposium on mechanisms of toxicology. New York: Macmillan; 1971:163–73.
Galle PR, Hofmann WJ, Walczak H et al. Involvement of the APO-1/Fas (CD95) receptor and ligand in liver damage. J Exp Med. 1995;182:1223.
Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci USA. 1994; 91:9995–9.
Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL-assay) fails to discriminate among apoptosis, necrosis and autolytic cell death, a cau-tionary note. Hepatology. 1995;21:1465–8.
Grasl-Kraupp B, Ruttkay-Nedecky B, Müllauer L et al. In-herent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology. 1997; 25:906–12.
Jones MEE, Haire MF, Kloetzel PM, Mykles DL, Schwartz LM. Changes in the structure and function of the multi-catalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, manduca sexta. Dev Biol. 1995;169:436–47.
Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.
Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol. 1995;154:1307–16.
Luebeck EG, Moolgavkar SH, Buchmann A, Schwarz M. Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci. Toxicol Appl Pharmacol. 1991;111:469–84.
Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K. Single GST-P positive liver cells-putative initiated hepatocytes. Carcinogenesis. 1987;8:483–6.
Muüllauer L, Grasl-Kraupp B, Bursch W, Schulte-Hermann R. Transforming growth factor b1-induced cell death in pre-neoplastic foci of rat liver and sensitization by the anti-estrogen tamoxifen. Hepatology. 1996;23:840–7.
Oberhammer F, Pavelka M, Sharma S. Induction of apoptosis in cultured hepatocytes and in regressing liver by transform-ing growth factor b1. Proc Natl Acad Sci USA. 1992;89: 5408–12.
Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. DNA synthesis, apoptosis and phenotypic ex-pression as determinatns of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 1990;50: 5127–35.
Schulte-Hermann R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver biology and disease. In: Boyer JL, Ockner RK, eds. Progress in liver disease.Vol. 13. Philadel-phia: WB Saunders; 1995:1–35.
Schweichel J-U, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology. 1973;7:253–66.
Stenius U. Different inhibition of DNA synthesis by transform-ing growth factor b and phenobarbital on GST-P-positive and GST-P-negative hepatocytes. Carcinogenesis. 1993;14: 159–61.
Tanno S, Ogawa K. Abundant TGF percursor and EGF receptor expression as a possible mechanism for the pre-ferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis. 1994;15: 1689–94.
Virchow R. Die Cellularpathologie in ihrer Begründung auf physiologische Gewebelehre. 4. Auflage, Berlin: Hirsch-wald; 1871.
Vogt C. Untersuchungen bei der Entwicklungs-geschichte der Geburtshelferkroete (Alytes obstericans). Solothurn: Jent and Gassman; 1842.
Wyllie AH. Apoptosis: cell death under homeostatic control. Mechanisms Methods Toxicol. 1987;11:3–10.
Zakeri Z, Bursch W, Tenniswood M, Lockshin RA. Cell death: programmed, apoptosis, necrosis, or other? Cell Death Differ. 1995;2:83–92.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schulte-Hermann, R., Bursch, W., Löw-Baselli, A. et al. Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol Toxicol 13, 339–348 (1997). https://doi.org/10.1023/A:1007495626864
Issue Date:
DOI: https://doi.org/10.1023/A:1007495626864